Evaluation of Molecular Hydrogen Supplementation to Enhance the Efficacy of Weight Loss Retreat in Overweight and Obese Adolescents
Launched by PALACKY UNIVERSITY · Apr 29, 2025
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether adding molecular hydrogen supplements can help overweight and obese teenagers lose weight more effectively during a 4-week weight loss retreat. The researchers will look at various factors, such as changes in body composition, fitness levels, and blood samples to check insulin sensitivity, fat levels, and markers of inflammation. The goal is to see if the hydrogen supplements make a positive difference in these areas.
To be eligible for the trial, participants must be between the ages of 4 and 17 and have a body mass index (BMI) that shows they are overweight or obese. Girls must have regular menstrual cycles, and a legal guardian must provide consent for them to join. However, individuals with certain health issues, like high blood pressure or heart problems, won’t be able to participate. If someone is selected for the trial, they can expect to engage in activities focused on weight loss and may receive the hydrogen supplements during this period. The study is not yet recruiting participants, but it aims to provide valuable insights into improving weight loss strategies for adolescents.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Body mass index indicating overweight or obesity, as determined according to the World Health Organization's international percentile charts for children aged 5-19 years.
- • Presence of a regular menstrual cycle in female participants.
- • Signed informed consent from the legal representative.
- Exclusion Criteria:
- • High blood pressure.
- • Dyslipoproteinemia.
- • Cardio-respiratory disorders.
- • Musculoskeletal disorders.
- • Use of any medications regulating heart rhythm or the neurovegetative and hormonal system.
About Palacky University
Palacký University, located in Olomouc, Czech Republic, is a prominent academic institution renowned for its commitment to research and innovation in the field of medicine and healthcare. With a robust focus on clinical trials, the university actively engages in advancing medical knowledge and improving patient outcomes through rigorous scientific investigation. Its interdisciplinary approach fosters collaboration among researchers, clinicians, and students, ensuring that the trials conducted are grounded in the latest scientific advancements. Palacký University is dedicated to maintaining high ethical standards and compliance with regulatory requirements, making it a trusted sponsor in the clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Olomouc, , Czech Republic
Olomouc, Czech Republic, Czechia
Patients applied
Trial Officials
Darja Supikova
Principal Investigator
Palacky University, Faculty of Physical Culture
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported